More on BCTXL
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.88 |
|
|||
| Open | $0.93 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.93 | ||||
| Day Low | $0.83 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 20,300 | ||||
- BriaCell Therapeutics Announces Pricing of Offering
- BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
- BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
- BriaCell adds Penn Medicine cancer center to phase 3 breast cancer trial
- BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
- BriaCell enrolls over 230 patients in phase 3 breast cancer study
- BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
- BriaCell adds NYU cancer center to phase 3 breast cancer trial
- BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
- BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer
Entities mentioned with BCTXL
- FDA | View Related Stories »
- ThinkEquity | View Related Stories »
- S1 | View Related Stories »
- S3 | View Related Stories »
- Show More...
